Susceptibility and resistance to systemic autoimmunity are genetically regulated. This is particularly true for murine mercury-induced autoimmunity (mHgIA) where DBA/2J mice are considered resistant to disease including polyclonal B cell activation, autoantibody responses, and immune complex deposits. To identify possible mechanisms for the resistance to mHgIA, we exposed mHgIA sensitive B10.S and resistant DBA/2J mice to HgCl 2 and assessed inflammation and pro-inflammatory responses at the site of exposure and subsequent development of markers of systemic autoimmunity. DBA/2J mice showed little evidence of induration at the site of exposure, expression of proinflammatory cytokines, T cell activation, or autoantibody production, although they did exhibit increased levels of total serum IgG and IgG1. In contrast B10.S mice developed significant inflammation together with increased expression of inflammasome component NLRP3, proinflammatory cytokines IL-1b, TNF-a, and IFN-c, hypergammaglobulinemia, splenomegaly, CD4 þ T-cell activation, and production of autoantibodies. Inflammation in B10.S mice was associated with a selective increase in activity of cysteine cathepsin B but not cathepsins L or S. Increased cathepsin B activity was not dependent on cytokines required for mHgIA but treatment with CA-074, a cathepsin B inhibitor, led to transient reduction of local induration, expression of inflammatory cytokines, and subsequent attenuation of the systemic adaptive immune response. These findings demonstrate that sensitivity to mHgIA is linked to an early cathepsin B regulated inflammatory response which can be pharmacologically exploited to abrogate the subsequent adaptive autoimmune response which leads to disease.
influenced by costimulatory molecules (Pollard et al., 2004) , cytokines (Kono et al., 1998) , and modulators of innate immunity (Vas et al., 2008) demonstrating that multiple checkpoints and pathways can be exploited to regulate disease. In addition, lupus prone strains exhibit accelerated and more severe systemic autoimmunity following mercury exposure (Pollard et al., 1999) .
Resistance to mHgIA lies with non-MHC genes as mouse strains with the same H-2 can have significantly different responses (Hultman et al., 1992) . We have shown that DBA/2J mice are resistant to mHgIA and that some of the genes involved lie within the Hmr1 locus at the distal end of chromosome 1 (Kono et al., 2001) . However, resistance to mHgIA in DBA/2J mice can be overcome by co-administration of lipopolysaccharides (LPS) (Abedi-Valugerdi et al., 2005) or anti-CTLA-4 treatment (Zheng and Monestier, 2003) arguing that modulation of both innate and adaptive immune pathways contributes to resistance to mHgIA. The DBA/2J is also resistant to experimental autoimmune orchitis (Tokunaga et al., 1993) and experimental allergic encephalomyelitis (Levine and Sowinski, 1973) suggesting that the mechanism of resistance is relevant to identifying therapeutic targets in both systemic-and organ-specific autoimmunity.
Elevated proinflammatory cytokines in humans with mercuryinduced autoimmunity (Gardner et al., 2010) and a dependence on IFN-c-and IFN-c-related genes in mHgIA suggest that inflammatory events may be important markers of sensitivity to mercury-induced autoimmunity. This is supported by studies showing that subcutaneous injection of HgCl 2 results in production of multiple cytokines in the skin overlying the injection site but not in draining lymph nodes or spleen (Pollard et al., 2011) . These studies suggest that mercury-induced inflammation may be important in the development of mHgIA.
To test this hypothesis, mHgIA sensitive B10.S and resistant DBA/2J mice exposed to HgCl 2 were examined for inflammation and pro-inflammatory markers at the site of exposure. Unlike B10.S mice, DBA/2J had little evidence of induration and expression of proinflammatory cytokines. DBA/2J also lacked splenomegaly, CD4
þ T-cell activation, and production of autoantibodies. The inflammatory response in B10.S mice was characterized by elevated cathepsin B activity. Cathepsin B, a lysosomal cysteine protease, involved in the degradation of cellular proteins, influences a variety of immunological processes including inflammasome activation, Toll-like receptor (TLR) signaling, antigen processing, cytokine regulation, T-cell differentiation, and apoptosis (Colbert et al., 2009; Hornung et al., 2008; Maekawa et al., 1998) . The cathepsin B inhibitor, CA-074 (Towatari et al., 1991) , reduces inflammasomemediated IL-1b production (Duncan et al., 2009) , and inflammation (Menzel et al., 2006) suggesting that it may be effective in inhibiting the local inflammatory response in mHgIA. Short-term treatment with CA-074 dramatically reduced expression of markers of inflammation in mHgIA including the inflammasome component NLRP3 (NLR family, pyrin domain containing 3), and cytokines IL-1b, TNF-a, and IFN-c. Longer treatment with CA-074 reduced signs of splenomegaly, lymphocyte activation, hypergammaglobulinemia, and autoantibodies compared with mice exposed to HgCl 2 alone. Our findings demonstrate that sensitivity to mHgIA is linked to an early cathepsin B regulated inflammatory response which is necessary for the subsequent adaptive autoimmune response leading to disease. Histology. Mice were sacrificed at either 7 or 14 days and skin overlying the site of mercury or PBS injection was excised and placed in 10% zinc formalin (Fisher Diagnostics, Middletown, Virginia). Briefly, sections (7 lm) were cut in a cryostat. Slides were placed in Harris Hematoxylin for 45 s, rinsed in double distilled water (ddH 2 0), washed in warm water for 4 min, placed in 1% Eosin for 1 min, washed in ddH 2 0 and then a series of washes was performed in 70% ethanol, 95% ethanol, 100% ethanol and xylene. Slides were mounted in permount (Sigma) and viewed under 10Â power.
MATERIALS AND METHODS
Skin score determination. B10.S and DBA/2J mice were exposed to mercury for 7 or 14 days. Skin lesion score was determined by estimation of induration at the site of injection. The loose skin over the upper neck and back were grasped between thumb and forefinger to allow an assessment of the skin thickness and the presence of any lesion at the site of injection noted. Animals were scored on a 1-4 scale (1-no induration/no lesion, 2-mild induration/no lesion, 3-moderate induration/with lesion, and 4-severe induration/with lesion). A score of 1 was defined as the preinjection induration for each individual mouse.
Real-time PCR. B10.S and DBA/2J mice were sacrificed after 7 or 14 days exposure and hair around injection site was removed by using Nair hair remover (Church & Dwight Co, Princeton, New Jersey). A 1.34 cm 2 piece of skin centered on the site of PBS or HgCl 2 injection was then excised and placed directly in TRIzol reagent (Invitrogen Life Technologies, La Jolla, California). Skin was homogenized by first cutting with a scalpel into fine slices and then vortexed vigorously for 1 min. Total RNA was purified using TRIzol reagent (Invitrogen Life Technologies) and contaminant DNA was removed using DNase I treatment at 37 C for 10 min (RNase Free DNase I, Invitrogen Life Technologies). One microgram of RNA was reverse transcribed in a total volume of 21 ml using random hexamers, dNTPs, RNase inhibitor (RNaseOUT; Invitrogen Life Technologies), and 200U of SuperScript III reverse transcriptase (Invitrogen Life Technologies). The cDNA levels of IFN-c, NALP3, IL-lb, and TNFa were measured by real-time PCR using primer sequences as previously described (Giulietti et al., 2001; Sutterwala et al., 2006; Toomey et al., 2010) . Levels of cytokines were analyzed using iQ SYBR-Green (Bio-Rad, Hercules, California). The reaction conditions were 94 C for 5 min, followed by 55 cycles of 20 s at 94 C and 30 s at 60 C, the melt curve used 70 cycles of 10 s at 60 þ 0.5 C. All PCR reactions were performed using an iCycler iQ (Bio-Rad Determination of TGFb1. B10.S and DBA/2J mice were sacrificed after 7 days of exposure and a skin biopsy taken centered on the site of PBS or HgCl 2 injection, snap frozen, and stored at À80 C as described above. Tissues were homogenized in 50 mM Tris [pH 7.4], 150 mM NaCl, 5 mM EDTA, 0.5% Nonidet P40, 0.5% deoxycholic acid, and 0.02% NaN 3 with protease inhibitor mixture (cOmplete EDTA free, Roche Diagnostics) using a MiniBeadBeater-1 and 2 mm zirconia beads and soluble protein obtained and quantified as described above. TGFb1 was determined by ELISA according to the manufacturer's instructions (R&D Systems, Minneapolis, Minnesota).
Treatment with cathepsin-
.44) (Peptide Institute Inc, Japan or EMD4Biosciences, Gibbstown, New Jersey) was used as a cathepsin B inhibitor as it is a more selective inhibitor that its methyl ester CA-074Me (Montaser et al., 2002) . As recommended by the manufacturer, CA-074 was diluted in dimethyl sulfoxide (DMSO). The compound was further diluted to 5% DMSO in PBS and 0.1 mg and 0.2 mg in 25 ml injected s.c. between the shoulder blades of B10.S mice every day for 7 or 14 days, respectively. Control B10.S mice received 5% DMSO in PBS alone. CA-074 has been solubilized in PBS (Maekawa et al., 1998 ) however this proved difficult in our hands.
Flow cytometry. B10.S and DBA/2J mice were sacrificed after 14 days of mercury exposure and total splenocyte numbers as well as T-cell numbers and activation status was assessed by flow cytometry as previously described with minor modifications (Pollard et al., 2011) . Prior to isolation, single cell suspensions of mouse spleens were obtained by manual mechanical homogenization, 35 mm cell filtration (Evergreen Scientific, Los Angeles, California) and red blood cells were depleted by 10 min at room temperature in red blood cell lysis buffer (eBiosciences, San Diego, California). Cell suspensions were stained with PerCPconjugated anti-CD4, FITC-conjugated anti-CD3, and conjugated anti-CD44 (BD Pharmingen). Fluorescence analysis was done using a dual laser BD FACSCalibur flow cytometer using CELLQuest Pro software (BD Biosciences, San Jose, California).
Further analysis was done using FlowJo software (Tree Star, Ashland, Oregon). Dead cells were excluded on the basis of forward and side scatter.
Serum IgG, IgG1, and IgG2a. B10.S and DBA/2J mice were sacrificed after 14 days of mercury exposure and serum levels of IgG, IgG1, and IgG2a antibodies were determined by ELISA, according to the manufacturer's instructions (Immunology Consultants Laboratory, Inc, Newburg, Oregon) as previously described (Pollard et al., 2011) . Briefly, serum was diluted 1/50 000 and incubated on polystyrene microtitre wells coated with anti-IgG, -IgG1, or -IgG2a. After a series of wash steps, the presence of bound immunoglobulin was determined by anti-IgG HRP conjugate. Chromogenic substrate was added and the assay was evaluated spectrophotometrically at 450 nm by the SPECTRA Max PLUS 384 spectrophotometer using Softmax Pro 3.1.1 software (Molecular Devices, Sunnyvale, California). Total serum levels were determined by linear regression analysis of the provided standard curve dilutions.
Antinuclear antibody test. B10.S and DBA/2J mice were treated with HgCl 2 for 14 days and serum antinuclear antibodies (ANA) determined by indirect immunofluoresence as described previously (Pollard et al., 2004) . Briefly, HEp-2 cells on glass slides (INOVA diagnostics, San Diego, California) were incubated with serum diluted 1/100. The presence of bound IgG was detected by a 1/200 dilution of Alexa Fluor 488-conjugated goat anti-mouse IgG (HþL) Abs (Molecular Probes, Carlsbad, California). Antinuclear antibody fluorescence intensity was graded on a 0-4þ scale under blinded conditions by an experienced observer. An intensity of 1þ or greater was called positive. The gradations in staining intensity were 1þ ¼ a clearly discernable nuclear staining, dull green in color, 2þ ¼ definite green fluorescence, 3þ ¼ bright green fluorescence tending toward yellow, and 4þ ¼ maximal fluorescence, brilliant yellow-green in color.
Anti-chromatin ELISA test. B10.S and DBA/2J mice were sacrificed after 14 days of mercury exposure and serum levels of antichromatin autoantibodies were determined using the QUANTA Lite Chromatin ELISA system (INOVA Diagnostics) modified to suit detection of murine antibodies as previously described . Briefly, serum was incubated at a dilution of 1/100. After a series of wash steps, the presence of bound antichromatin antibodies was determined by goat anti-mouse IgG HRPO conjugate (Caltag Labs, Burlingame, CA) diluted 1/200. After addition of the chromogenic substrate, the assay was evaluated spectrophotometrically at 450 nm by a SPECTRA Max PLUS 384 spectrophotometer using Softmax Pro 3.1.1 software (Molecular Devices). Data were expressed as total absorbance.
Statistical analysis. All data were expressed as the mean and SE. Analysis was done using GraphPad Prism5 (GraphPad Software, San Diego, California). P values less than 0.05 were considered significant.
RESULTS
mHgIA-Resistant DBA/2 Mice Lack Evidence of Induration at the Site of HgCl 2 Exposure Mercury exposure induces an inflammatory response, particularly at the site of exposure (Pollard et al., 2011) , however the contribution of such inflammation to mHgIA is unclear. Histological examination of skin overlying the injection site revealed that HgCl 2 exposure resulted in a much more dramatic TOOMEY ET AL. | 341 thickening of the dermis and hypodermis of mHgIA sensitive B10.S compared with mHgIA-resistant DBA/2J mice ( Figure 1A ). This thickening of the skin was supported by increases in skin score in B10.S mice on days 3 and 7 (P < 0.0001) ( Figure 1B ). DBA/ 2J mice also showed increases in skin score on days 3 and 7 (P < 0.05), however, skin scores were greater in the B10.S mice (P < 0.05). Thus, mHgIA-resistant DBA/2J mice have significantly less skin inflammation than mHgIA-sensitive B10.S mice following HgCl 2 injection.
mHgIA-Resistant DBA/2 Mice Lack Markers of Inflammation at the Site of HgCl 2 Exposure
To determine whether the differences in HgCl 2 -induced inflammation between DBA/2J and B10.S are also reflected in the expression of proinflammatory cytokines and inflammasome components, mRNA expression was determined using real-time PCR. In B10.S mice, HgCl 2 exposure resulted in significant increases in IFN-c, TNF-a, IL-1b, and the inflammasome component NRLP3 (P < 0.05) compared with PBS controls (Figure 2 ). DBA/2J mice showed no increase in IFN-c, TNF-a, or IL-1b expression following HgCl 2 exposure, although they did have a modest increase in NLRP3 (P < 0.05) (Figure 2 ). Additionally, compared with the DBA/2J mice, HgCl 2 exposure in B10.S mice resulted in increased expression of IFN-c, TNF-a, IL-1b, and NRLP3 (P < 0.05) (Figure 2) . Thus, mercury exposure in the mHgIA-sensitive B10.S mice leads to increases in mRNA expression of proinflammatory cytokines and the inflammasome component NRLP3, consistent with the greater induration observed in the skin (Figure 1 ). In contrast, the mHgIA-resistant DBA/2J showed no evidence of increased expression of proinflammatory cytokines including IL-1b even though there was a modest increase in NLRP3 expression.
mHgIA-Sensitive Mice Have a Selective Increase in Cathepsin B Activity Compared with mHgIA-Resistant Mice
Cathepsins help regulate inflammatory responses via effects on IL-1b and the NLRP3 inflammasome (Duncan et al., 2009) , and other proinflammatory cytokines via processing of TLRs (Garcia-Cattaneo et al., 2012) . This suggested that the increased inflammation in mHgIA-sensitive B10.S mice might be explained by increased activity of cathepsins. This was assessed by determining the activity of cathepsins B, L, and S at the site of exposure in mHgIA-sensitive mice (B10.S and C57BL/6.SJL) compared with the mHgIA-resistant DBA/2J. Although DBA/2J mice had increased cathepsin B activity following mercury exposure (P < 0.01), this was significantly less than that found in mercury exposed B10.S (P < 0.002) or C57BL/6.SJL (P < 0.01) and dramatically less when compared with pooled data from B10.S and C57BL/6.SJL (H-2 s ) (P < 0.0001) ( Figure 3A ). Background levels of cathepsin B were elevated in B10.S and C57BL/6.SJL compared with DBA/2J mice (P < 0.0002). B10.S and C57BL/6.SJL showed no differences in their cathepsin B responses to mercury or PBS. In contrast, HgCl 2 exposure increased the activity of cathepsin L ( Figure 3B ) and cathepsin S ( Figure 3C ) in both B10.S and DBA/2J mice. These studies show that the presence of a HgCl 2 -induced inflammatory response in B10.S mice is associated with a selective increase in cathepsin B activity which is significantly attenuated in the HgCl 2 -resistant DBA/2J strain.
Increased TGF-b1 Does Not Explain the Reduced Cathepsin B Activity in DBA/2 Mice As TGF-b1 suppresses cathepsin B activity (Gerber et al., 2001) , we asked if an increase in TGF-b1 explains the difference in cathepsin B activity between B10.S and DBA/2 mice following mercury exposure. As shown in Figure 4 , mercury exposure significantly increased TGF-b1 levels in both DBA/2 and B10.S mice suggesting that increased TGF-b1 is not responsible for failure of HgCl 2 to increase cathepsin B activity in the DBA/2.
Cathepsin B Inhibitor CA-074 Suppresses Inflammatory Markers in Skin of B10.S Mice After 7 Days of HgCl 2 Exposure To ascertain if inhibition of cathepsin B could suppress expression of proinflammatory cytokines and inflammasome components in HgCl 2 -induced inflammation, B10.S mice were injected with the cathepsin B inhibitor CA-074. Consistent with the observations in Figure 2 mercury exposure of B10.S mice resulted in significant increases in the expression of IFNc, TNF-a, IL-1b, and NRLP3 (P < 0.05) compared with PBS controls ( Figure 5 ). In striking contrast mice treated with HgCl 2 and CA-074 failed to develop increased expression of TNF-a, IL-1b, or NRLP3 but did have an increase in IFN-c (P < 0.05) ( Figure 5 ). Compared with mercury alone, treatment with CA-074 and mercury resulted in decreases expression of TNF-a, IL-1b, IFN-c, and NRLP3 (P < 0.05). The data show that inhibition of cathepsin B suppresses the expression of proinflammatory cytokines and the inflammasome component NRLP3 in mHgIA-sensitive B10.S mice following exposure to mercury. 
CA-074 Reduces Features of Autoimmunity in mHgIA-Sensitive B10.S Mice After 14 Days of HgCl 2 Exposure
The ability of CA-074 to suppress markers of inflammation in the skin of HgCl 2 -exposed B10.S mice implied that this compound might reduce features of humoral autoimmunity. To test this possibility, we first determined that a 2-week exposure to HgCl 2 could induce features of autoimmunity in B10.S but not DBA/2J mice. As shown in Table 1 , HgCl 2 exposure produced splenomegaly and an increase in activated CD4 þ T cells in B10.S mice but not DBA/2J mice. Mercury exposure also resulted in hypergammaglobulinemia, with increases in IgG (P < 0.002), IgG1 (P < 0.006), and IgG2a (P < 0.0002), in B10.S mice (Table 2 ). Mercury exposed DBA/2J mice also showed evidence of hypergammaglobulinemia, with significant increases in IgG (P < 0.02) and IgG1 (P < 0.0001) but not IgG2a. However, unlike B10.S mice this was not associated with the presence of ANA or anti-chromatin autoantibodies (Table 2) . Two week treatment of B10.S mice with CA-074 (0.2 mg/day) lowered mean values of IgG (P < 0.005) compared with control B10.S mice treated with PBS only (Table 2) suggesting that CA-074 changes baseline serum immunoglobulin levels. Mercury exposure significantly increased IgG (P < 0.0001), IgG1 (P < 0.0001), and IgG2a (P < 0.0001), and autoantibodies (ANA, P < 0.0005 and anti-chromatin abs, P < 0.0001). Although the levels of IgG (P < 0.01), IgG2a (P < 0.01), and autoantibodies (ANA, P < 0.05 and anti-chromatin abs, P < 0.01) remained elevated in mercury exposed mice treated with CA-074 they were nevertheless significantly decreased from mice receiving mercury alone ( Table 2) . Treatment of mercury exposed B10.S mice with CA-074 suppressed splenomegaly and the HgCl 2 -induced increase in CD4 þ T-cell activation (Table 1) . Thus, inhibition of cathepsin B significantly reduces features of the adaptive immune response of mHgIA.
CA-074 Delays Appearance of Skin Induration in mHgIASensitive B10.S Mice After 14 Days of HgCl 2 Exposure
Reduction in features of autoimmunity in mice treated with CA-074 for 2 weeks suggested that CA-074 mediated inhibition of cathepsin B may also reduce the magnitude of the inflammatory response in the skin ( Figure 6A ). CA-074 treatment significantly decreased the severity of skin scores compared with mercury exposed controls particularly during the first week of exposure (P < 0.05) ( Figure 6B ). HgCl 2 -and CA-074-treated mice did have significant increases in skin score from day 5-13 (P < 0.05) when compared with PBS-and CA-074-treated mice. As expected, mercury exposure of B10.S mice led to significant increases in skin score assessments from day 1 to the final day 13 (P < 0.0001). Thus, CA-074 treatment delayed the appearance and severity of skin induration and inflammation following exposure to HgCl 2 .
Longer Exposure to HgCl 2 Overcomes CA-074 Suppression of Inflammatory Markers in Skin of mHgIA-Sensitive B10.S Mice The increase in the magnitude of the skin score in CA-074-treated mice ( Figure 6B ) during a 2-week exposure to mercury suggested a restoration of proinflammatory cytokine expression. This was confirmed by real-time PCR measurement of TNF-a, IL-1b, and NRLP3 (P < 0.05) in mice treated with CA-074 and mercury (Figure 7 ). Two weeks of mercury exposure in B10.S mice resulted in statistically significant increases in IFN-c, IL-1b, and TNF-a expression (P < 0.05) (Figure 7 ) which were not different from mercury exposed B10.S treated with CA-074. Thus, the early inhibition of proinflammatory markers in B10.S mice by CA-074 ( Figure 5 ) was overcome by longer exposure to HgCl 2 . This supports the observation that CA-074 delays the severity of skin induration and inflammation following longer exposure to HgCl 2 ( Figure 6B ) and suggests that CA-074 impedes the HgCl 2 -induced inflammatory response but does not suppress it. DBA/2J mice exposed to mercury for 2 weeks showed significant increases in expression of NRLP3 (P < 0.05) but no changes in the expression of IFN-c, IL-1b, or TNF-a. Thus, mHgIA-resistant DBA/2J mice show a consistent lack of markers of inflammation. These results demonstrate that inhibition of cathepsin B delayed the appearance and severity of the localized inflammatory response induced by exposure to HgCl 2 . ) and DBA/2J mice. B, Cathepsin L activity in B10.S and DBA/2J mice. C, Cathepsin S activity in B10.S and DBA/2J mice. *P < 0.05; **P < 0.01; ***P < 0.002; ****P < 0.0001. N ¼ 6-8/group for B10.S, N ¼ 4/group for C57BL/6.SJL, N ¼ 8 for DBA/2J receiving PBS and 7 for DBA/2J receiving a Statistical significance comparing untreated PBS or mercury exposed mice to the respective PBS or mercury exposed treatment of CA-074 treatment group (P < 0.05).
b Statistical significance compared with the mercury exposed group to the respective PBS control group (P < 0.05).
c Statistical significance comparing DBA/2J mice to the respective PBS or mercury exposed B10.S strain (P < 0.05). Data are presented as mean 6 SE. b Statistical significance compared with the mercury exposed group to the respective PBS control group (P < 0.05).
c Statistical significance comparing DBA/2J mice to the respective PBS or mercury exposed B10.S strain (P < 0.05). Data are presented as mean 6 SE AU, arbitrary unit.
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Proinflammatory Cytokines Required for mHgIA Are Not Required for HgCl 2 Mediated Increased Cathepsin B Activity Both IFN-c and IL-6 are required for mHgIA whereas caspase 1, which is responsible for the processing of IL-1b, is not (Havarinasab et al., 2009; Pollard et al., 2012) . To determine whether these proinflammatory mediators are required for HgCl 2 -induced increase in cathepsin B activity B10.S-Ifng
B10.S-Il6
À/À , and B10.S-Casp1 À/À mice were exposed to HgCl 2 before determining cathepsin B activity (Figure 8 ). Absence of IFN-c and IL-6 had no effect on the induction of cathepsin B activity ( Figures 8A and 8B ), and although activity was somewhat reduced in B10.S-Casp1
À/À compared with wild-type mice, this was not significant ( Figure 8C ). These findings suggest that proinflammatory mediators required for HgCl 2 -induced autoimmunity affect events downstream of the activation of cathepsin B.
DISCUSSION
Among the spectrum of autoimmune features induced in various strains of mice by mercury, the DBA/2J stands out as one of the most resistant. It does not develop the polyclonal B-cell activation (Abedi-Valugerdi et al., 2005) , autoantibody responses, or immune complex deposits (Kono et al., 2001 ) seen in mHgIAsensitive strains. Although resistance of the DBA/2J to glomerular immune complex deposits has been linked to a single major quantitative trait locus on chromosome 1, designated Hmr1 (Kono et al., 2001) , the failure to develop earlier stages of disease, including inflammation and humoral autoimmunity, has not been addressed. In this study, we noted that the DBA/2J, unlike the mHgIA-sensitive B10.S, fails to develop induration at the site of exposure. Instead the skin over the upper neck and back of DBA/2J mice remained loose and pliable indicating a lack of inflammation. Furthermore, apart from modest increases in NLRP3 expression and cathepsin B activity, DBA/2J mice lack the increase in expression of markers of inflammation seen in the mHgIA-sensitive B10.S. Unlike previous reports (AbediValugerdi et al., 2005) , the mercury exposed DBA/2J mice in this study did show evidence of hypergammaglobulinemia although this was not accompanied by T-cell activation or autoantibodies.
In a previous study, mHgIA-sensitive B10.S showed evidence of increased expression of multiple proinflammatory cytokines in the skin overlying the injection site but not in draining lymph nodes or spleen (Pollard et al., 2011) ; IL-4 was increased in the spleen (Kono et al., 1998) . As shown here this localized inflammatory response includes increased expression of proinflammatory cytokines IL-1b and TNF-a prior to the appearance of humoral autoimmunity. This suggests significant contribution by the innate immune response which is supported by the increased expression of NLRP3, which leads to caspase-1 activation and cleavage of pro-IL-1b and pro-IL-18, via lysosomal membrane destabilization and activation of the lysosomal cysteine protease cathepsin B (Franchi et al., 2009) . Cathepsins can also regulate inflammatory responses via effects on processing of TLRs (Garcia-Cattaneo et al., 2012) . Our examination of several cysteine cathepsins revealed a selective increase in cathepsin B activity in B10.S mice compared with DBA/2J. Furthermore, our data show that this selective increase in cathepsin B is an early event in the proinflammatory response following HgCl 2 exposure making cathepsin B an attractive pharmacologic target. The cathepsin B-specific inhibitor CA-074 prevents caspase-1 activation (Newman et al., 2009) , signaling activities of the NLRP3 and ASC-containing inflammasome and IL-1b and IL-18 maturation (Duncan et al., 2009) . Mercury has been shown to localize in lysosomes of macrophages and endothelial cells (Christensen, 1996) and to mediate cathepsin B release from microglia (Sakamoto et al., 2008) leading us to hypothesize that CA-074 might inhibit early events in mercury-induced inflammation and provide insight into the mechanism leading to lack of inflammation in DBA/2J mice. CA-074 did significantly reduce mRNA production of the inflammatory cytokines IL-1b, TNF-a, and IFN-c and the inflammasome component NRLP3 during 7 days of HgCl 2 exposure. Inhibition of cathepsin B by CA-074 has been shown to modulate cytokine expression (Duncan et al., 2009) , however it is unlikely that the mechanism is a direct effect on mRNA levels although an influence on posttranslational processing events is a possibility, especially for TNF-a (Ha et al., 2008) . The most plausible explanation for the CA-074-mediated reduction of mRNA levels of inflammatory markers found in this study is a reduction in cellular infiltrates at the site of HgCl 2 injection.
Inhibition of the HgCl 2 -induced inflammatory response was transient as CA-074-treated mice did show evidence of proinflammatory cytokine expression with a longer exposure to mercury. Nonetheless, compared with mice exposed to HgCl 2 alone, concurrent CA-074 treatment reduced splenomegaly, T-cell activation, and serum immunoglobulins and autoantibodies. The exact mechanism of action of CA-074 in dampening the severity of mHgIA is unclear as cathepsin B impacts immune responses in many ways including antigen processing and presentation, cytokine activation and turnover, T-cell differentiation, TLR signaling and lysosomal-mediated apoptosis (Colbert et al., 2009; Lalanne et al., 2010) . Even though IL-1b is increased in mHgIA, a role for the NLRP3 inflammasome is unlikely as absence of either NLRP3 or caspase 1 has little effect on development of disease . Effects on inflammation, apoptosis, export of TNF-a, and cell migration have all been proposed as possible mechanisms for reduced incidence of diabetes in cathepsin B-deficient NOD mice (Hsing et al., 2010) . The same dose of CA-074 used here (0.2 mg/day) suppressed immune responses to hepatitis B and rabies vaccines in mice (Matsunaga et al., 1993) . Higher doses led to a shift toward a Th1-dominated immune response in mice infected with Leishmania major (Maekawa et al., 1998) ; IL-4, IgE, and IgG1 responses were suppressed and IFN-c and IgG2a increased. This may explain why CA-074 was not able to reduce the expression of IFN-c and IgG2a antibodies to control levels, although, these levels were significantly lower than in mice exposed to mercury alone. More importantly, the presence of a Th1 response in CA-074-treated mice may explain the development of proinflammatory cytokine expression with longer treatment as induction of mHgIA is dependent upon IFN-c. Absence of IFN-c suppresses hypergammaglobulinemia, autoantibodies, and immune complex deposition but not T-cell activation . It is possible , and C, B10.S-Casp1 À/À . *P < 0.01; **P < 0.002; ***P < 0.005. N ¼ 7-12/group. TOOMEY ET AL. | 347 that the suppression of inflammatory factors by CA-074 during the first 7 days involves events that are not IFN-c dependent as absence of IFN-c did not affect HgCl 2 -induced increase in cathepsin B activity. Similar observations were made with IL-6-and caspase 1-deficient mice suggesting that the effects of these proinflammatory mediators on mHgIA are downstream of the regulation of cathepsin B activity.
In conclusion, we report that resistance to mHgIA in DBA/2J mice is associated with the absence of a local inflammatory response at the site of HgCl 2 exposure. Attempts to model such resistance using CA-074, a cathepsin B inhibitor, in mHgIAsensitive mice delayed the inflammatory response and dampened the severity of mHgIA. The data demonstrate that development of mHgIA is coupled to an inflammatory response the magnitude of which is influenced by cathepsin B. 
